Clinical Trial Update: FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion

View source ↗

Summary

A clinical trial update indicates fibroblast activation protein inhibitor (FAPI) imaging may predict adverse cardiac events in patients with chronic total occlu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Total Occlusion

Drugs mentioned

• FAPI imaging agent (fibroblast activation protein inhibitor tracer)

Snippet

Sponsor: Lin Zhao | Conditions: Chronic Total Occlusion (CTO), Chronic Coronary Syndrome | Status: RECRUITING